Astellas touts data from early test of stem cell-derived eye therapy

Astellas reported promising results with its stem cell-derived therapy in an age-related eye disease, though data in a handful of high-dose patients in the early-stage study raised questions. The experimental stem cell therapy, called ASP7317 ...